positions available now

Category Archives: Market Access

Relating to Market Access sector of Life Sciences Industry

PBAC Outcomes – November 2019

The November 2019 PBAC Meeting Outcomes were published recently With 61 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making for this meeting, compared to the past 5 years of outcomes. Of note, … Continue reading

Posted in Market Access, PBAC | Tagged , , , | Comments Off on PBAC Outcomes – November 2019

Pharmac reverses controversial brand switch decision

Pharmac has been placed in the spotlight over their decision earlier in the year to fund only one brand of anti-epileptic medication, lamotrigine, instead of the previously funded three lamotrigine brands. Prior to the switch, Medsafe warned Pharmac that the … Continue reading

Posted in Market Access | Tagged , , , , | Comments Off on Pharmac reverses controversial brand switch decision

Commercial Eyes appoints Simon Higgins to head up new Commercialisation Services division

Commercial Eyes Pty. Ltd., one of Australia’s most successful health technology commercialisation companies, is pleased to announce the appointment of Simon Higgins to head up it’s new Commercialisation Services division. Simon joins Commercial Eyes with over 20 years’ experience in … Continue reading

Posted in Commercial Eyes, Commercialisation Services, Market Access, Market Insight, Medical Communications, Medical Services, Regulatory Services | Tagged , , , , | Comments Off on Commercial Eyes appoints Simon Higgins to head up new Commercialisation Services division

PHARMAC prepares to take over the procurement of medical devices

Access to medical devices in New Zealand is changing   The Therapeutic Products Bill will be published shortly, resulting in PHARMAC assuming responsibility for the procurement and funding of medical devices in addition to their current brief of medicines. This … Continue reading

Posted in Life Sciences Industry, Market Access, Medical Device | Tagged , , , , , , | Comments Off on PHARMAC prepares to take over the procurement of medical devices

PHARMAC issues a call for funding applications for medicines for rare disorders

Applications will be accepted until 5pm on the 5th of August 2019 and will be considered by the Rare Disorders Subcommittee at their meeting scheduled for the 24th of September 2019.   Eligibility criteria: The medicine must have been approved … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on PHARMAC issues a call for funding applications for medicines for rare disorders

November 2018 PBAC Meeting Agenda

The November 2018 PBAC Meeting is scheduled to conclude today. Here, the Commercial Eyes Market Access team provides an analysis of the meeting agenda, including Sponsors with multiple submissions and the nature of requested listings by type.     The … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , | Comments Off on November 2018 PBAC Meeting Agenda

PBAC Meeting Outcomes – July 2018

The July 2018 PBAC Meeting Outcomes were published on 17th August 2018. With 64 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including additional analysis conducted on biosimilar and oncology submissions.   … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , | Comments Off on PBAC Meeting Outcomes – July 2018

Public Submissions to the August 2018 PBAC Special Meeting – Part 2

In the second part of this two-part series (Read Part 1 about here) we bring you further insight into opinions from the public submissions to the August 2018 PBAC Special Meeting. Opinions from the Public Submissions Outcomes of the PBAC’s … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , , | Comments Off on Public Submissions to the August 2018 PBAC Special Meeting – Part 2

Public Submissions to the August 2018 PBAC Special Meeting – Part 1

In the first of a two-part series, we provide insights into opinions from 28 public submissions to the August 2018 PBAC Special Meeting held on 17 August 2018 regarding considerations for PD-1 and PD-L1 checkpoint inhibitors for multiple cancer types … Continue reading

Posted in Market Access, PBAC, PBS, Uncategorized | Tagged , , , , | Comments Off on Public Submissions to the August 2018 PBAC Special Meeting – Part 1

PBAC Special Meeting – August 2018

The August 2018 PBAC special meeting is scheduled for 17 August 2018 to consider options for listing PD-1 and PD-L1 checkpoint inhibitors for the treatment of multiple tumours (pan-tumour indications) on the PBS. Here, the Commercial Eyes Market Access team … Continue reading

Posted in Market Access, PBAC | Tagged , , , , , | Comments Off on PBAC Special Meeting – August 2018
Copyright © 2014 Commercial Eyes